PASG Q4 2025 Earnings — Passage Bio, Inc. Revenue & Financial Results | Market Cap Arena

PASGPassage Bio, Inc.

$29M

Q4 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$200,000

Operating Income

-$14M

Net Income

-$13M

EPS (Diluted)

$-3.98

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$609,000

Balance Sheet

Total Assets

$62M

Total Liabilities

$44M

Stockholders' Equity

$19M

Cash & Equivalents

$46M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$200,000	-$719,000	+127.8%
Operating Income	-$14M	-$14M	+3.0%
Net Income	-$13M	-$13M	-2.0%